INSTITUTO FINLAY DE VACUNAS

Trials shown by sponsor

Public title	Date of Registration	State
Sinopharm-SOBERANA COVID-Cienfuegos	30/08/2022	Registered
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain	29/12/2016	Registered
SOBERANA PLUS PEDIATRIA	28/09/2021	Registered outdated
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II.	28/04/2017	Registered outdated
SOBERANA 02	27/10/2020	Registered
SOBERANA CENTRO	23/07/2021	Registered outdated
SOBERANA PEDIATRIA CLINICA 1	23/07/2021	Registered outdated
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study	22/05/2020	Registered outdated
VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2	22/05/2020	Registered
Clinical Trial with the Outer Membrane Vesicles (OMV) Bivalent AW135 Anti meningocóccal Vacccine Candidate	2013-06-19	Registered
Study of the tetanus vaccine vax-TET®-5	2013-06-10	Registered
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba.	2008-09-19	Registered
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique.	2008-09-12	Registered
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain.	2008-09-12	Registered
Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants.	2008-07-29	Registered
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers.	2008-07-29	Registered
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age.	2008-07-29	Registered
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET.	2008-07-29	Registered
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine.	2008-07-29	Registered
To evaluate the immunogenicity and safety of SOBERANA® 02 and SOBERANA® Plus as booster of immunity against the omicrom variant of SARS-CoV-2, in adult subjects	19/05/2023	Registered

Registered Trials

Registration process

INSTITUTO FINLAY DE VACUNAS

About the RPCEC

Useful resources